A European project innovating advanced cell-therapy for Diabetes
Improving the lives of people with diabetes
World renowned
Diabetes expertise
Discover
ISLET
The ISLET project has come to a close – it was funded by The European Union’s Horizon 2020 Research and Innovation Programme between March 2020 – 2026.
ISLET was spearheaded by a unique scientific team that share an ambitious common goal: to pioneer a new advanced cell therapy for Type 1 Diabetes. The team combined the wealth of expertise, facilities and knowledge of seven institutions to allow key findings to be translated into a therapy. As a team ISLET has a unique power to improve the lives of people living with diabetes, not just through therapy, but through advanced public engagement and communication.
Living with
Diabetes
With 463 million people worldwide living with diabetes there is a large demand for new treatments. Diabetes is a chronic disease with no cure. It occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Take a glance into the life of someone with the condition.
Advanced
Therapies
An advanced therapy uses new medical products that involve gene therapy, cell therapy, and tissue engineering. This is a fast evolving area with ground-breaking potential for the future treatment of a wide-array of diseases and injuries. Delve into the science of these approaches.
